Alternatives for malaria prophylaxis during the first trimester of pregnancy: our personal view.
Hellgren
Urban
U
Department of Infectious Diseases, Karolinska Institute, Stockholm, Sweden.
Rombo
Lars
L
D000962:Antimalarials / Q000009:adverse effects / Q000627:therapeutic use*; D053626:Atovaquone / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008288:Malaria / Q000517:prevention & control*; D015767:Mefloquine / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000517:prevention & control*; D011261:Pregnancy Trimester, First; D002727:Proguanil / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors; D013548:Sweden; D013754:Tetracyclines / Q000009:adverse effects / Q000627:therapeutic use
D000962:Antimalarials; D013754:Tetracyclines; D002727:Proguanil; D015767:Mefloquine; D053626:Atovaquone